Charles River Laboratories International CRL
NYSE CRL
$282.06 +8.65 (+3.16%)
As of: Sep 17, 2026 · 3:59 PM EDT

Charles River Laboratories International (CRL) Other Working Capital Changes (2016 - 2026)

Charles River Laboratories International (CRL) posted Other Working Capital Changes of -$18.3 million for Q1 2018, down 546.8% on a QoQ basis from $4.1 million in Q2 2017, and down 546.8% year-over-year from $4.1 million in Q1 2017.

Analysis

Charles River Laboratories International (CRL) Other Working Capital Changes (2016 - 2026) Analysis & Trends

Charles River Laboratories International has reported Other Working Capital Changes for 10 years, with the latest figure at -$18.3 million in Q1 2018.

  • On a quarterly basis, Other Working Capital Changes fell 546.8% year-over-year to -$18.3 million in Q1 2018; TTM through Mar 2018 was -$643000.0, a 103.27% decrease from a year earlier, with the FY2016 full-year figure at $14.6 million, up 132.39% from the prior year.
  • Other Working Capital Changes was -$18.3 million for Q1 2018 at Charles River Laboratories International, down from $4.1 million in the prior quarter.
  • The five-year high for Other Working Capital Changes was $43.1 million in Q3 2025, with the low at -$103.4 million in Q4 2025.
  • Average Other Working Capital Changes over 5 years is $3.0 million, with a median of $10.2 million recorded in 2026.
  • The sharpest annual moves came in 2014 and 2018: Other Working Capital Changes soared 1431.15% in 2014, then tumbled 546.8% in 2018.
  • Over 5 years, Other Working Capital Changes stood at $13.4 million in 2014, then sank by 62.6% to $5.0 million in 2015, then surged by 147.28% to $12.4 million in 2016, then plunged by 67.01% to $4.1 million in 2017, then sank by 546.8% to -$18.3 million in 2018.
  • The last three Other Working Capital Changes figures came in at -$18.3 million (Q1 2018), $4.1 million (Q2 2017), and $12.4 million (Q4 2016), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 11.81 Mn
Jun 27, 2026 11.81 Mn
Mar 28, 2026 8.52 Mn
Mar 28, 2026 8.52 Mn
Dec 27, 2025 -103.42 Mn
Dec 27, 2025 -103.42 Mn
Sep 27, 2025 43.07 Mn
Sep 27, 2025 43.07 Mn
Jun 28, 2025 26.26 Mn
Jun 28, 2025 26.26 Mn
Mar 29, 2025 -4.05 Mn
Mar 29, 2025 -4.05 Mn
Dec 28, 2024 12.76 Mn
Dec 28, 2024 12.76 Mn
Sep 28, 2024 -7.42 Mn
Sep 28, 2024 -7.42 Mn
Jun 29, 2024 13.64 Mn
Jun 29, 2024 13.64 Mn
Mar 30, 2024 33.02 Mn
Mar 30, 2024 33.02 Mn